Literature DB >> 15226247

Introduction to surrogate markers.

Jay N Cohn1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15226247     DOI： 10.1161/01.CIR.0000133441.05780.1d

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

Review 1.  Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.

Authors:  Søren M Bentzen; Matthew Parliament; Joseph O Deasy; Adam Dicker; Walter J Curran; Jacqueline P Williams; Barry S Rosenstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Airborne particulate matter exposure and urinary albumin excretion: the Multi-Ethnic Study of Atherosclerosis.

Authors:  M S O'Neill; A V Diez-Roux; A H Auchincloss; T G Franklin; D R Jacobs; B C Astor; J T Dvonch; J Kaufman
Journal:  Occup Environ Med       Date:  2007-11-21       Impact factor: 4.402

Review 3.  Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk.

Authors:  Todd J Anderson
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

4.  State of the science on cardiometabolic risk after spinal cord injury: recap of the 2013 Asia pre-conference on cardiometabolic disease.

Authors:  Manon Maitland Schladen; Suzanne L Groah
Journal:  Top Spinal Cord Inj Rehabil       Date:  2014

Review 5.  When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project.

Authors:  Costan G Magnussen; Harri Niinikoski; Markus Juonala; Mika Kivimäki; Tapani Rönnemaa; Jorma S A Viikari; Olli Simell; Olli T Raitakari
Journal:  Pediatr Nephrol       Date:  2011-08-30       Impact factor: 3.714

6.  The challenges of outcome research.

Authors:  Lene Juel Kjeldsen; Trine Rune Høgh Nielsen; Charlotte Olesen
Journal:  Int J Clin Pharm       Date:  2016-04-02

Review 7.  Microalbuminuria as surrogate endpoint in therapeutic trials.

Authors:  Josep Redon; Fernando Martinez
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 8.  Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.

Authors:  Kristin M Corapi; Mary Anne Dooley; William F Pendergraft
Journal:  Arthritis Res Ther       Date:  2015-04-28       Impact factor: 5.156

9.  How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use.

Authors:  Gantt P Galloway; Edward G Singleton
Journal:  Subst Abuse       Date:  2009-08-26

10.  Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice.

Authors:  Cláudia Maria Vilas Freire; Antonio Luiz Pinho Ribeiro; Felipe Batista Lima Barbosa; Anelise Impelisiere Nogueira; Maria Cristina Costa de Almeida; Márcia Melo Barbosa; Angela Maria Quintão Lana; Ana Cristina Simões e Silva; Antônio Ribeiro-Oliveira
Journal:  Vasc Health Risk Manag       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.